Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for treatment of mild to moderate postpartum depression
IRCT20090117001556N125Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of celecoxib in postpartum depression (PPD), sponsored by Tehran University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
celecoxib
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on IRCT20090117001556N125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N125.